PIANOFORTE is a partnership funded by EURATOM with the vision to provide a pan-European scientific and technological basis for a robust system of protection and more consolidated science-based policy recommendations to decision makers in all these different fields and – at the same time – to innovate in ionising radiation based medical applications combating cancer and other diseases by new and optimised diagnostic and therapeutic approaches always considering radiation safety. In the long term, these efforts will translate into additional or improved practical measures through innovation and improved scientific insights in view of a better outcome of patients suffering from cancer and the effective protection of people (public, workers and patients) and the environment.
Involving 58 partners across 22 EU countries as well as the UK and Norway, the ambition of this Partnership is to have an impact on radiation protection of humans and the environment in many ways. By gaining and consolidating scientific knowledge, the results of the research activities will support the implementation of the European Basic Safety Standards, to help cope with the new requirements and harmonize the practices throughout Europe. The holistic approach covers both fundamental science for exposure and effects, risk assessment, perception and management, as well as development of measurement techniques, innovative tools, methods and best practices to cope with the existing and emerging issues related to radiation exposure, thus creating a major impact for society. Research is needed for risk prediction in specific situations and for foresight, to anticipate potential exposures. New knowledge will contribute to evidence-based recommendations at international level and informed risk communication.
Launch of the PIANOFORTE European partnership: research and education for radiation protection